Table 2.

Long-term evolution of SARS-CoV-2 IgG antibodies in AU/mL and the respective neutralizing effect in 24 patients on hemodialysis

Long-term follow-up data in 24 hemodialysis patients
		1	2	3	4
IgG	Mean	11	91	67	46
	STD	22	24	29	36
	95% CI	2–21	80–101	51–84	31–61
cPASS	Mean	25	83	69	65
	STD	20	26	30	25
	95% CI	17–34	72–94	57–82	54–76
Days	Mean	44	35	94	135
	STD	19	19	32	36
	95% CI	35–52	27–43	80–108	120–150

Measurement 1 was performed on average 11 days after the first vaccination, measurements 2–4 were performed on average 35, 94, and 135 days after the second standard dose vaccination